vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and LANTRONIX INC (LTRX). Click either name above to swap in a different company.

LANTRONIX INC is the larger business by last-quarter revenue ($29.8M vs $24.8M, roughly 1.2× Ceribell, Inc.). LANTRONIX INC runs the higher net margin — -4.5% vs -54.6%, a 50.1% gap on every dollar of revenue. LANTRONIX INC produced more free cash flow last quarter ($2.1M vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

Lantronix Inc is a global provider of secure IoT connectivity and edge computing solutions. It offers specialized hardware, SaaS platforms and embedded software for industrial, healthcare, retail, transportation and smart city clients worldwide, supporting reliable remote device management.

CBLL vs LTRX — Head-to-Head

Bigger by revenue
LTRX
LTRX
1.2× larger
LTRX
$29.8M
$24.8M
CBLL
Higher net margin
LTRX
LTRX
50.1% more per $
LTRX
-4.5%
-54.6%
CBLL
More free cash flow
LTRX
LTRX
$13.0M more FCF
LTRX
$2.1M
$-11.0M
CBLL

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CBLL
CBLL
LTRX
LTRX
Revenue
$24.8M
$29.8M
Net Profit
$-13.5M
$-1.3M
Gross Margin
87.3%
43.6%
Operating Margin
-58.9%
-3.6%
Net Margin
-54.6%
-4.5%
Revenue YoY
-4.5%
Net Profit YoY
43.9%
EPS (diluted)
$-0.35
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
LTRX
LTRX
Q4 25
$24.8M
$29.8M
Q3 25
$22.6M
$29.8M
Q2 25
$21.2M
$28.8M
Q1 25
$20.5M
$28.5M
Q4 24
$31.2M
Q3 24
$17.2M
$34.4M
Q2 24
$49.1M
Q1 24
$41.2M
Net Profit
CBLL
CBLL
LTRX
LTRX
Q4 25
$-13.5M
$-1.3M
Q3 25
$-13.5M
$-1.4M
Q2 25
$-13.6M
$-2.6M
Q1 25
$-12.8M
$-3.9M
Q4 24
$-2.4M
Q3 24
$-10.4M
$-2.5M
Q2 24
$386.0K
Q1 24
$-423.0K
Gross Margin
CBLL
CBLL
LTRX
LTRX
Q4 25
87.3%
43.6%
Q3 25
88.3%
44.8%
Q2 25
88.1%
40.0%
Q1 25
87.9%
43.5%
Q4 24
42.6%
Q3 24
87.3%
42.1%
Q2 24
38.1%
Q1 24
40.1%
Operating Margin
CBLL
CBLL
LTRX
LTRX
Q4 25
-58.9%
-3.6%
Q3 25
-64.8%
-5.1%
Q2 25
-70.5%
-10.9%
Q1 25
-69.3%
-12.6%
Q4 24
-6.9%
Q3 24
-57.8%
-6.2%
Q2 24
1.2%
Q1 24
-0.2%
Net Margin
CBLL
CBLL
LTRX
LTRX
Q4 25
-54.6%
-4.5%
Q3 25
-59.6%
-4.7%
Q2 25
-64.4%
-9.1%
Q1 25
-62.4%
-13.6%
Q4 24
-7.6%
Q3 24
-60.6%
-7.3%
Q2 24
0.8%
Q1 24
-1.0%
EPS (diluted)
CBLL
CBLL
LTRX
LTRX
Q4 25
$-0.35
$-0.03
Q3 25
$-0.37
$-0.04
Q2 25
$-0.38
$-0.06
Q1 25
$-0.36
$-0.10
Q4 24
$-0.06
Q3 24
$-1.85
$-0.07
Q2 24
$0.01
Q1 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
LTRX
LTRX
Cash + ST InvestmentsLiquidity on hand
$159.3M
$23.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
$74.4M
Total Assets
$195.8M
$121.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
LTRX
LTRX
Q4 25
$159.3M
$23.0M
Q3 25
$168.5M
$22.2M
Q2 25
$177.4M
$20.1M
Q1 25
$182.7M
$20.0M
Q4 24
$19.2M
Q3 24
$14.1M
$26.4M
Q2 24
$26.2M
Q1 24
$24.6M
Stockholders' Equity
CBLL
CBLL
LTRX
LTRX
Q4 25
$155.3M
$74.4M
Q3 25
$164.1M
$74.5M
Q2 25
$172.2M
$74.4M
Q1 25
$180.9M
$75.5M
Q4 24
$77.9M
Q3 24
$-136.0M
$78.9M
Q2 24
$81.4M
Q1 24
$78.1M
Total Assets
CBLL
CBLL
LTRX
LTRX
Q4 25
$195.8M
$121.7M
Q3 25
$199.5M
$119.6M
Q2 25
$207.7M
$123.7M
Q1 25
$213.5M
$124.2M
Q4 24
$134.2M
Q3 24
$47.1M
$137.9M
Q2 24
$136.2M
Q1 24
$147.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
LTRX
LTRX
Operating Cash FlowLast quarter
$-10.8M
$2.2M
Free Cash FlowOCF − Capex
$-11.0M
$2.1M
FCF MarginFCF / Revenue
-44.2%
7.0%
Capex IntensityCapex / Revenue
0.7%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M
$9.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
LTRX
LTRX
Q4 25
$-10.8M
$2.2M
Q3 25
$-11.1M
$3.6M
Q2 25
$-7.5M
$1.1M
Q1 25
$-11.4M
$3.2M
Q4 24
$340.0K
Q3 24
$2.7M
Q2 24
$2.3M
Q1 24
$3.6M
Free Cash Flow
CBLL
CBLL
LTRX
LTRX
Q4 25
$-11.0M
$2.1M
Q3 25
$-11.5M
$3.5M
Q2 25
$-7.6M
$909.0K
Q1 25
$-11.6M
$3.1M
Q4 24
$256.0K
Q3 24
$2.5M
Q2 24
$2.1M
Q1 24
$3.5M
FCF Margin
CBLL
CBLL
LTRX
LTRX
Q4 25
-44.2%
7.0%
Q3 25
-50.8%
11.9%
Q2 25
-35.9%
3.2%
Q1 25
-56.4%
10.9%
Q4 24
0.8%
Q3 24
7.3%
Q2 24
4.3%
Q1 24
8.4%
Capex Intensity
CBLL
CBLL
LTRX
LTRX
Q4 25
0.7%
0.3%
Q3 25
1.6%
0.2%
Q2 25
0.3%
0.5%
Q1 25
0.7%
0.4%
Q4 24
0.3%
Q3 24
0.5%
Q2 24
0.3%
Q1 24
0.3%
Cash Conversion
CBLL
CBLL
LTRX
LTRX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
5.89×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

LTRX
LTRX

Embedded Io T Solutions$13.9M47%
Io T System Solutions$13.3M45%
Software And Services$2.6M9%

Related Comparisons